Stromal Therapeutics

Basel, Switzerland

Stromal Therapeutics is the biotechnological spin-off from the Kantonsspital St.Gallen.

$537K raised

Jan 2022

Seed

Biotechnology Therapeutics

Top Investors

BaseLaunch

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Stromal Therapeutics

How much funding has Stromal Therapeutics raised?

Stromal Therapeutics has raised $537K in total funding. The most recent round was Seed. The last funding was announced in January 2022.

Who are Stromal Therapeutics's investors?

Stromal Therapeutics's investors include BaseLaunch.

Where is Stromal Therapeutics headquartered?

Stromal Therapeutics is headquartered in Basel, Switzerland.

What does Stromal Therapeutics do?

Stromal Therapeutics is the biotechnological spin-off from the Kantonsspital St.Gallen.

What stage is Stromal Therapeutics at?

Stromal Therapeutics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 28, 2022.

MLA

"Stromal Therapeutics — Funding & Investors." VCBacked, January 28, 2022, https://www.vcbacked.co/company/stromal-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2022). Stromal Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/stromal-therapeutics

Wikipedia (cite web)

{{cite web |title=Stromal Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/stromal-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 28, 2022.